Proactive Investors - Run By Investors For Investors

Namaste Technologies says two board members, Kiran Sidhu and Sefi Dollinger step down

Kiran Sidhu and Sefi Dollinger are leaving the cannabis company's board
cannabis plant
Toronto-based Namaste, which has been described as the “Amazon of cannabis,” operates the largest global cannabis e-commerce platform

Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTTF) said Thursday that Kiran Sidhu and Sefi Dollinger have resigned from its board to pursue other interests.

In the wake of Sidhu and Dollinger’s departures, the Canadian cannabis company is looking to add up to two independent directors and is holding discussions with potential candidates.

READ: Namaste Technologies looks to become the ‘Amazon of cannabis’ with its integrated, intelligent cannabis experience

Namaste’s board is now made up of Laurens Feenstra, Kenneth Ngo and Branden Spikes, former chief information officer at Elon Musk’s SpaceX, who serves as chairman.

Toronto-based Namaste, which has been described as the “Amazon of cannabis,” operates the largest global cannabis e-commerce platform with over 30 websites in more than 20 countries under a variety of brands.

READ: Namaste sees green in edibles, buys a stake in Choklat for C$1.5M

In addition to its product offerings of vaporizers, glassware, accessories and CBD products, the company is also involved in the world of medical cannabis, through its licensed subsidiary CannMart Inc, not to mention its efforts in artificial intelligence, cannabis strain research and a global telemedicine app, as well as the sales of medical cannabis from its facility in Toronto.

Namaste shares slipped C$0.12 to finish at C$0.76 on Wednesday.

Contact Ellen Kelleher at [email protected]

View full N profile View Profile

Namaste Technologies Inc Timeline

Related Articles

scientist in a lab
April 12 2019
Danish giant Novo Nordisk recently signed up to use its NDD platform, and bosses expect more collaboration deals in the coming months
1550834286_shutterstock_651647128.jpg
February 22 2019
The company is developing drugs for blood disorders, metabolic diseases and curbing alcohol use
A paper rocket is ready to launch on a surgeon's scissors
March 29 2019
The company hopes to improve its share price with ADAPT technology successes.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use